SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 89 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $131,362 | +122668.2% | 17,422 | +30.6% | 0.00% | 0.0% |
| Q1 2023 | $107 | -20.7% | 13,340 | -10.4% | 0.00% | -33.3% |
| Q4 2022 | $135 | -99.9% | 14,892 | -14.1% | 0.00% | 0.0% |
| Q3 2022 | $120,000 | +39.5% | 17,327 | +10.5% | 0.00% | +50.0% |
| Q2 2022 | $86,000 | -62.6% | 15,681 | -12.0% | 0.00% | -60.0% |
| Q1 2022 | $230,000 | -3.4% | 17,820 | +18.8% | 0.01% | -28.6% |
| Q2 2019 | $238,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |